Inventor · disambiguated record
Alexis S. Statham
Also filed as: STATHAM ALEXIS S
33 granted patents·3 pending applications·971 citations·filing 2006–2014
98Inventor score
Files with3M INNOVATIVE PROPERTIES CO29STATHAM ALEXIS S3AMOS DAVID T23M INNOVATIVE PROERTIES COMPANY1STOESZ JAMES D1
Top patents by PatentIndex Score
36 records- 0199US7902245B2Methods for reducing imiquimod impurities for two months, four months, and six months3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Mar 8, 2011·54 cites·9 claims
- 0299US7902210B2Reduction of IMIQUIMOD impurities at two months using refined oleic acid3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Mar 8, 2011·65 cites·20 claims
- 0399US7902211B2Method of inducing interferon biosynthesis3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Mar 8, 2011·70 cites·20 claims
- 0499US7902214B2Method of treating a mucosal and/or dermal associated condition3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Mar 8, 2011·71 cites·13 claims
- 0599US7902242B2Method of stabilizing imiquimod3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Mar 8, 2011·54 cites·20 claims
- 0699US7902213B2Pharmaceutical cream with reduced imiquimod impurities at four months using refined oleic acid3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Mar 8, 2011·67 cites·10 claims
- 0799US7902246B2Methods for controlling formation of imiquimod impurities for two months, four months, and six months3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Mar 8, 2011·54 cites·9 claims
- 0899US7902243B2Methods for improving imiquimod availability at two months, four months and six months between refined and compendial3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Mar 8, 2011·54 cites·20 claims
- 0999US7902215B2Pharmaceutical creams with reduced imiquimod impurities3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Mar 8, 2011·68 cites·12 claims
- 1099US7902212B2Reduction of imiquimod impurities at six months using refined oleic acid3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Mar 8, 2011·64 cites·20 claims
- 1199US7902244B2Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation (at least four months storage)3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Mar 8, 2011·54 cites·20 claims
- 1299US7902216B2Pharmaceutical creams with refined oleic acid3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Mar 8, 2011·65 cites·9 claims
- 1399US7655672B2Immune response modifier formulations containing oleic acid and methods3M INNOVATIVE PROPERTIES CO·Filed 2008·Granted Feb 2, 2010·73 cites·20 claims
- 1496US7928116B2Method of treating actinic keratosis3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Apr 19, 2011·17 cites·20 claims
- 1596US7928117B2Method of inducing cytokine biosynthesis3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Apr 19, 2011·17 cites·20 claims
- 1696US7906526B2Method of treating a dermal and/or mucosal associated condition3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Mar 15, 2011·16 cites·20 claims
- 1796US7902209B2Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation3M INNOVATIVE PROERTIES COMPANY·Filed 2010·Granted Mar 8, 2011·54 cites·20 claims
- 1894US7928118B2Reduction of imiquimod impurities in pharmaceutical creams3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Apr 19, 2011·11 cites·20 claims
- 1994US7906527B2Reduction of imiquimod impurities using refined oleic acid3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Mar 15, 2011·11 cites·19 claims
- 2093US7915277B2Method of treating genital or peri-anal warts3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Mar 29, 2011·10 cites·20 claims
- 2193US7906525B2Reduction of imiquimod impurities at four months using refined oleic acid3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Mar 15, 2011·10 cites·17 claims
- 2293US7906524B2Pharmaceutical cream having similar or less levels of imiquimod impurity formation as cream with BHA (comparator)3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Mar 15, 2011·10 cites·18 claims
- 2379US8557838B2Immune response modifier formulations containing oleic acid and methodsSTATHAM ALEXIS S·Filed 2011·Granted Oct 15, 2013·1 cites·18 claims
- 2479US8080560B2Immune response modifier formulations containing oleic acid and methodsSTATHAM ALEXIS S·Filed 2006·Granted Dec 20, 2011·1 cites·132 claims
- 2563US7939555B2Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted May 10, 2011·0 cites·20 claims
- 2663US7923463B2Methods for stabilizing imiquimod for two months, four months, and six months3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Apr 12, 2011·0 cites·9 claims
- 2763US7919501B2Method of controlling formation of imiquimod impurities3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Apr 5, 2011·0 cites·20 claims
- 2863US7915278B2Method of treating basal cell carcinoma3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Mar 29, 2011·0 cites·20 claims
- 2963US7915279B2Method of treating mollescum contagiosum3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Mar 29, 2011·0 cites·20 claims
- 3063US7906543B2Method of reducing imiquimod impurity formation3M INNOVATIVE PROPERTIES CO·Filed 2010·Granted Mar 15, 2011·0 cites·20 claims
- 3161US9522211B2Antimicrobial disposable absorbent articles3M INNOVATIVE PROPERTIES CO·Filed 2014·Granted Dec 20, 2016·0 cites·17 claims
- 3255US2008200890A1Antimicrobial disposable absorbent articles3M INNOVATIVE PROPERTIES CO·Filed 2008·Application pending·0 cites
- 3350US2013165880A1Antimicrobial disposable absorbent articlesAMOS DAVID T·Filed 2011·Application pending·0 cites
- 3448US8124096B2Immune response modifier compositions and methodsSTOESZ JAMES D·Filed 2007·Granted Feb 28, 2012·0 cites·38 claims
- 3547US8889154B2Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulationSTATHAM ALEXIS S·Filed 2006·Granted Nov 18, 2014·0 cites·81 claims
- 3640US2012070480A1Antimicrobial disposable absorbent articlesAMOS DAVID T·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →